927 results on '"Choi, Chel Hun"'
Search Results
2. Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity Score Matching Study in Korea and Taiwan
3. Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
4. Effects of subcutaneous drain on wound dehiscence and infection in gynecological midline laparotomy: Secondary analysis of a Korean Gynecologic Oncology Group study (KGOG 4001)
5. Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia – Multicenter retrospective study (KGOG2033)
6. A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis
7. Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
8. Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial
9. ASO Visual Abstract: Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity-Score-Matching Study in Korea and Taiwan
10. Survival outcomes of laparoscopic versus open radical hysterectomy in early cervical cancer with incidentally identified high-risk factors
11. The Effect of Intrathecal Morphine on Postoperative Opioid Consumption in Patients Undergoing Abdominal Surgery for Gynecologic Malignancy: A Randomized Sham-Controlled Trial
12. An open label, single arm phase II, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16- or 18-positive cervical cancer and failure of first-line platinum-based chemotherapy (DURBAC).
13. Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol
14. Clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience
15. Efficacy and safety of BVAC-C in HPV type 16- or 18–positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study
16. Advantages of laparoscopy in gynecologic surgery in elderly patients
17. Determination of ovarian transposition through prediction of postoperative adjuvant therapy in young patients with early stage cervical cancer undergoing surgery: a Korean multicenter retrospective study (KGOG 1042)
18. Comparison of RNA-Seq and microarray in the prediction of protein expression and survival prediction
19. Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus–Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern
20. DOMENICA study (GINECO-EN105b/ENGOT-en13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1)
21. Feasibility of articulating laparoscopic instrument in laparoscopic adnexectomy: a multinational prospective observational study
22. Preliminary efficacy of pembrolizumab plus lenvatinib in recurrent clear cell gynecological cancer: Phase II LARA trial (GCGS-OV4/APGOT-OV3)
23. Transition and prognostic implications of 2009 to 2023 FIGO staging in endometrial cancer: a retrospective cohort study from stage I to IIIA
24. Oncologic outcomes and the impact of minimally invasive surgery in early-stage cervical cancer patients undergoing radical trachelectomy: a Korean Gynecologic Oncology Group study (KGOG 1048)
25. Final primary analysis in the original cohort of KGOG3046/TRU-D: a phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer
26. Comparison of various progestin treatments in patients with atypical endometrial hyperplasia: multicenter retrospective study (COPIA, KGOG2033)
27. Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): a phase II umbrella trial
28. Oregovomab and non-platinum chemotherapy in PARP inhibitor-resistant ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: a multicenter, two-cohort, single-arm phase 2 trial (OPERA/KGOG 3065/APGOT-OV6)
29. Initial experience with the enhanced recovery after surgery (ERAS) protocols in gynecologic surgery at an urban academic tertiary medical center
30. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
31. Metabolic syndrome and persistent cervical human papillomavirus infection
32. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer
33. CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer
34. Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis
35. TP003/#1557 An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive cervical cancer (DURBAC)
36. TP016/#1542 A multicenter study of niraparib as maintenance therapy in BRCA wild-type, newly diagnosed advanced ovarian cancer (Polo trial)
37. TP018/#822 A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer
38. EP011/#717 Prediction of chemotherapy response with liquid biopsy of body fluid from patients with gynecologic cancer
39. EP396/#252 Effect of fascia closure using barbed suture on incisional hernia in midline laparotomy for gynecological diseases (Barbher trial, KGOG 4001)
40. EP128/#505 Impact of different adjuvant treatment approaches on survival in high-risk endometrial carcinoma: a multicenter study
41. EP012/#719 Genome-wide cell-free DNA analysis algorithms for early detection and prediction of prognosis of ovarian cancer
42. EP256/#833 Retrospective analysis comparing the survival outcome of niraparib and olaparib in advanced ovarian cancer patients
43. PR012/#858 Comparisons of survival outcomes of laparoscopic versus open radical hysterectomy in early cervical cancer with incidentally identified pathologic high-risk factors
44. PR008/#805 Efficacy and safety of BVAC-C in HPV type 16 or 18 positive cervical carcinoma who failed 1st platinum based chemotherapy: a phase I/IIA study
45. EP258/#917 Recurrence-free survival and overall survival in early-stage ovarian cancer considering homologous recombination deficiency(HRD) status
46. EP370/#835 Diagnostic accuracy of cytology test in HPV-independent cervical adenocarcinoma
47. TP005/#1524 Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICR: a phase III, randomized controlled clinical trial (KGOG1047; Debulk trial)
48. PR069/#709 Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: a Korean multicenter cohort study
49. EP307/#763 Clinicopathologic factors associated with long-term survival in advanced epithelial ovarian cancer
50. Reply to: Comments on “Randomized, two‐arm, non‐comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.